Literature DB >> 1245841

Diversity of lymphocytic choriomeningitis virus: variation due to replication of the virus in the mouse.

M Popescu, F Lehmann-Grube.   

Abstract

Depending on passage history, strain WE infectious LCM virus either damages L cells more or less severely or leaves them morphologically intact. Correspondingly, the plaques which are formed on L cell monolayers are of different appearance, ranging from intensely turbid to clear. Multiplication of LCM virus in certain mouse organs profoundly affects plaque characteristics. The brain, for instance, favours lytic variants while the spleen supports the replication of virus which forms turbid plaques. This statement holds if virus taken from organs of persistently infected mice or virus passaged from mouse to mouse is analysed and is true also if the initial preparation contains virus forming predominantly either clear or turbid plaques on L cell monolayers. Selection is not rapid and not absolute. It may take months of multiplication before a final state is reached, and even then the number of characteristic plaques is usually in great excess of the rest but never reaches 100%. Cloning procedures may alter the proportions, but with our experimental conditions no plaque has ever been isolated which would retain its characteristics upon passage. Differences of plaque type morphology were not reflected in differences of pathogenic properties, and both clear and turbid variants caused persistent infection if used to infect newborn mice and led to disease with signs of neurological involvement and death if inoculated intracerebrally into adult animals.

Entities:  

Mesh:

Year:  1976        PMID: 1245841     DOI: 10.1099/0022-1317-30-1-113

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

1.  In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes.

Authors:  T Aebischer; D Moskophidis; U H Rohrer; R M Zinkernagel; H Hengartner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

2.  Homologous interference of lymphocytic choriomeningitis virus: detection and measurement of interference focus-forming units.

Authors:  M Popescu; H Schaefer; F Lehmann-Grube
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

3.  Very high frequency of reversion to guanidine resistance in clonal pools of guanidine-dependent type 1 poliovirus.

Authors:  J C de la Torre; E Wimmer; J J Holland
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  Secondary cytotoxic cell response to lymphocytic choriomeningitis virus. III. In vivo protective activity of effector cells generated in vitro.

Authors:  M B Dunlop
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

5.  Regulation of Pichinde virus replication in Vero and BHK-21 cells.

Authors:  P R Young; S R Lee; C R Howard
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

6.  Emergence of virus escape mutants after immunization with epitope vaccine.

Authors:  G Weidt; W Deppert; O Utermöhlen; J Heukeshoven; F Lehmann-Grube
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Tissue-mediated selection of viral variants: correlation between glycoprotein mutation and growth in neuronal cells.

Authors:  L Villarete; T Somasundaram; R Ahmed
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

8.  Lymphocytic choriomeningitis virus. II. Characterization of extractable complement-fixing activity.

Authors:  H H Geschwender; G Rutter; F Lehmann-Grube
Journal:  Med Microbiol Immunol       Date:  1976-06-01       Impact factor: 3.402

9.  Lymphocytic choriomeningitis virus. IV. Electron microscopic investigation of the virion.

Authors:  G Müller; M Bruns; L Martínez Peralta; F Lehmann-Grube
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

10.  Heterogeneity of the mutation rates of influenza A viruses: isolation of mutator mutants.

Authors:  P Suárez; J Valcárcel; J Ortín
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.